Autopsy report · NCT05746871

Safety and Performance of Agilik in CP

“The study was discontinued after the expiration of Ethics Committee approval, as the required conditions to continue the trial were no longer available.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 2 years 10 months before it stopped.
• 9 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

IRCCS Eugenio Medea

Sponsor type

University, hospital or other

Conditions

Cerebral Palsy

Interventions

Agilik; standard care

Participants

9

Sites

1

Countries

Italy

Trials that died the same way

• A Study Of PF-06664178 In Patients With Advanced Solid Tumors
  “The study was prematurely discontinued due to a business-related decision on 09-FEB-2016. The decision to terminate the trial was based on the overall results.” (79% match in meaning)
• Safety and Efficacy of MAGE-A3/A6 T Cell Receptor Engineered T Cells (KITE-718) in HLA-DPB1*04:01 Positive Adults With Advanced Cancers
  “The study was terminated due to the sponsor's decision to discontinue the clinical trial.” (77% match in meaning)
• A Long Term Safety Study of Mavrilimumab in Adult Subjects With Rheumatoid Arthritis
  “The study was terminated after approximately 3 years due to future clinical development plans, including ethical considerations.” (75% match in meaning)
• Integrative Liver-Targeted Therapy for Diabetic Macular Edema: Using "Tauroursodeoxycholate" or Traditional Chinese Medicine.
  “The study was terminated due to additional regulatory requirements that could not be completed within the established academic timeline. As a result, continuation of the study was not feasible.” (75% match in meaning)
• Structured Light Plethysmography Against Standard of Care in the Diagnosis and Monitoring of Dysfunctional Breathing
  “Study terminated/withdrawn due to the prolonged timeline since initial ethical approval (without starting) and the number of significant changes to the management and structure of the study deemed appropriate for continuation due to the delays.” (75% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.